Found 0 matching trials
Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I) PHASE2 This phase II MATCH treatment trial identifies the effects of GDC-0032 (tas...
Show More Status
Active Not Recruiting
Location
ECOG-ACRIN Cancer Research Group
Learn More & Join Trial
Prevalence of Spontaneous Pneumothorax in BHD PHASE1 To assess the prevalence of BHD (Birt-Hogg-Dubé syndrome) among patients wi...
Show More Learn More & Join Trial
Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma N/A Clinical trial to evaluate the performance characteristics(sensitivity and ...
Show More Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University,
Learn More & Join Trial
Worm Study: Modifier Genes in Sudden Cardiac Death NA Quest for modifier genes associated with ventricular arrhythmias in presenc...
Show More Location
Maastricht University Medical Center
Learn More & Join Trial
Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations PHASE2 This study is a Phase 2 trial designed to evaluate the clinical efficacy, s...
Show More Status
Active Not Recruiting
Location
Cincinnati Children's Hospital
Learn More & Join Trial
Furmonertinib 160mg as First-line Treatment in Locally Advanced or Metastatic NSCLC With EGFR Classical Mutations PHASE3 To evaluate the efficacy, safety, recurrence site, recurrence pattern and r...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib. PHASE1 This is an open label, non-randomized, sequential, phase I/II trial in pati...
Show More Location
Hospital de la Santa Creu i Sant Pau
Learn More & Join Trial
Characterization of a Functional Test for Mediterranean Family Fever Screening - 2 N/A Familial Mediterranean fever (FMF) is the most common auto-inflammatory dis...
Show More Location
Hôpital Femme-Mère-Enfant
Learn More & Join Trial
A Study to Assess Biomarkers Impact on Participants Response to Erlotinib Treatment for First-line Non-Small Cell Lung Cancer With Endothelial Growth Factor Receptor (EGFR) Activating Mutations PHASE2 This open-label, single-arm, multi-center study will evaluate the progressi...
Show More Location
County Hospital Alba; Oncology
Learn More & Join Trial
Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases PHASE2 This is a prospective, open-label, multi-center, single-arm clinical trial...
Location
Cancer Hospital Affiliated to University of Chinese Academy of Sciences
Learn More & Join Trial